Ten innovations spanning diagnostics, AI, mobility, mitochondria and regenerative medicine have been recognized at a Hong Kong summit.

A Tokyo startup called TIME TRAVELER thinks the antiaging answer was sitting in the vegetable drawer all along.

Zsolt Farkas of Evolut on why today's longevity valuations only work if the winners spend the next decade buying everything ...

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that ...

The maker of sasineprocel, a patient-derived cell therapy, has published its preclinical work in Cell Stem Cell as it heads toward Phase 3. The raw material for Aspen Neuroscience’s Parkinson’s ...

A retrospective study of 345 paired tests found 83.5% of patients improved, held steady or declined slowly, with no control group. On average, the patients in this study were 74.6 years old and living ...

Basecamp Research will train AI models on the world’s largest biological dataset and design new medicines. Most AI ...

Aging Research and Drug Discovery meeting opened with a pitch for prevention and a program building the endpoints the field needs.

Younger founder Christin Glorioso on turning a six-month competition into a side-by-side trial of aging clocks.

Postgraduate program aims to turn geroscience, biomarkers and emerging technologies into evidence-based healthspan medicine for physicians. Longevity medicine has never been short of theory; what it ...